﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2009v1.4">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2011-04-13T09:07:18-05:00</Timestamp>
    <TaxPeriodEndDate>2010-05-31</TaxPeriodEndDate>
    <PreparerFirm>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>Tate and Tryon</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>2021 L Street NW Suite 400</AddressLine1>
        <City>Washington</City>
        <State>DC</State>
        <ZIPCode>20036</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2009-06-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>237033369</EIN>
      <Name>
        <BusinessNameLine1>AMERICAN SOCIETY OF HEALTH-SYSTEM</BusinessNameLine1>
        <BusinessNameLine2>PHARMACISTS RESEARCH AND EDUCATION FDTN</BusinessNameLine2>
      </Name>
      <NameControl>AMER</NameControl>
      <Phone>3016648612</Phone>
      <USAddress>
        <AddressLine1>7272 WISCONSIN AVENUE 2ND FLOOR</AddressLine1>
        <City>BETHESDA</City>
        <State>MD</State>
        <ZIPCode>20814</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>STEPHEN J ALLEN</Name>
      <Title>EXECUTIVE VICE PRESIDENT AND CEO</Title>
      <Phone>3016648612</Phone>
      <DateSigned>2011-04-13</DateSigned>
      <AuthorizeThirdParty>1</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Name>DEBORAH G KOSNETT</Name>
      <Phone>2022932200</Phone>
    </Preparer>
    <TaxYear>2009</TaxYear>
    <BuildTS>2016-02-24 21:20:13Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="9">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <NameOfPrincipalOfficerPerson>STEPHEN J ALLEN</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>7272 WISCONSIN AVENUE 2ND FLOOR</AddressLine1>
        <City>BETHESDA</City>
        <State>MD</State>
        <ZIPCode>20814</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>3378384</GrossReceipts>
      <GroupReturnForAffiliates>0</GroupReturnForAffiliates>
      <Organization501c typeOf501cOrganization="3">X</Organization501c>
      <WebSite>WWW.ASHPFOUNDATION.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>1968</YearFormation>
      <StateLegalDomicile>MD</StateLegalDomicile>
      <ActivityOrMissionDescription>FOSTERING SAFE AND EFFECITVE MEDICATION USE. TO PROMOTE THE PUBLIC INTEREST THROUGH DEVELOPMENT OF HIGH QUALITY PHARMACEUTICAL SERVICES IN HEALTH SYSTEMS. TO ENCOURAGE, PROVIDE FOR AND ENGAGE IN SCIENTIFIC RESEARCH, PROFESSIONAL STUDY AND ADVANCEMENT OF THE SCIENCE OF PHARMACY IN HEALTH SYSTEMS. TO IMPROVE THE QUALITY AND INCREASE THE AVAILABILITY OF PHARMACEUTICAL SERVICES TO THE PUBLIC.</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>11</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>9</NbrIndependentVotingMembers>
      <TotalNbrEmployees>0</TotalNbrEmployees>
      <TotalNbrVolunteers>100</TotalNbrVolunteers>
      <TotalGrossUBI>0</TotalGrossUBI>
      <NetUnrelatedBusinessTxblIncome>0</NetUnrelatedBusinessTxblIncome>
      <ContributionsGrantsPriorYear>1610656</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>1993575</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenuePriorYear>131189</ProgramServiceRevenuePriorYear>
      <ProgramServiceRevenueCY>155612</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>-2139511</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>1220437</InvestmentIncomeCurrentYear>
      <OtherRevenuePriorYear>-8864</OtherRevenuePriorYear>
      <OtherRevenueCurrentYear>-9853</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>-406530</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>3359771</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>564069</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>497824</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>1068454</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>1057637</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>352987</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>791819</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>748340</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>2424342</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>2303801</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>-2830872</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>1055970</RevenuesLessExpensesCY>
      <TotalAssetsBOY>8730826</TotalAssetsBOY>
      <TotalAssetsEOY>9832251</TotalAssetsEOY>
      <TotalLiabilitiesBOY>226249</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>271704</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>8504577</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>9560547</NetAssetsOrFundBalancesEOY>
      <MissionDescription>The mission of the ASHP Foundation is to improve the health and well-being of patients in hospitals and health systems through appropriate, safe and effective medication use. The Foundation provides leadership and conducts education and research activities that foster the coordination of interdisciplinary medication management leading to optimal patient outcomes. Emphasis is given to programs that will have a major impact on advancing pharmacy practice in hospitals and health systems, thereby improving public health.</MissionDescription>
      <SignificantNewProgramServices>0</SignificantNewProgramServices>
      <SignificantChange>0</SignificantChange>
      <Expense>768245</Expense>
      <Grants>132560</Grants>
      <Revenue>155612</Revenue>
      <Description>EXPANSION OF PHARMACISTS' DIRECT PATIENT CARE AND LEADERSHIP ROLES ASHP Foundation Research Advisory Panel-The Research Advisory Panel (RAP) met once during FY 10 and the Senior Director for Research and Operations worked closely with several panel members to facilitate implementation of several RAP recommendations for the Foundation's research agenda. These included guidance on the Foundation's grant review process, research misconduct language, and the future role of the RAP.Center for Health-System Pharmacy Leadership-The Center was developed as a collaborative programmatic offering of ASHP and the ASHP Foundation, and is administered by the Foundation. The Center has been in operation since January 2007 and its primary objectives are to: (1) assure that pharmacy leaders have the knowledge necessary to proactively influence the advancement of the medication-use process by providing competency-based education opportunities, (2) provide leadership development programs for students, residents and new practitioners that promote the important role of the pharmacist as a change agent and a leader in patient care, (3) integrate into health-system leadership decision-making the critical role for pharmacists as active participants in achieving organizational objectives, (4) conduct research on effective pharmacy management and leadership in achieving the objectives of hospitals and health systems, as well as improving community disease prevention and health promotion efforts and (5) explore the purpose and value of a credential for hospital and health-system pharmacy leaders that recognizes competencies to direct the medication-use systems enterprise and promote safety and cost-effective medication outcomes.The Center Advisory Panel (CAP)-This advisory panel was established in FY 08 and is a 12-member group that serves as an external resource of experts providing an environmental scan of practice issues and significant events that might affect the Center's plan of action. In addition, members provide expert advice on the Center's current direction, program development and possible actions that the Center should consider as it builds its program portfolio. The CAP met twice in FY 10.Pharmacy Leadership Academy-The Pharmacy Leadership Academy is supported by Amgen. The Pharmacy Leadership Academy is designed to provide additional comprehensive training to pharmacy leaders beyond what is learned in pharmacy residencies, short courses and other educational programs. The Academy provides leadership training applicable to clinical and administrative pharmacy practitioners in small to large hospitals and health systems who aspire to leadership positions in health-system pharmacy.Leadership Learning Community-The Center for Health-System Pharmacy Leadership hosted a successful learning community at the June 2010 ASHP Summer Meeting entitled "Leading Results with NQF 18." The 5-session series offered over 11 hours of material and had an esteemed faculty of senior pharmacists and health-system executives from a variety of health-system settings.Pharmacy Leadership Institute (PLI)-Since 2008, the Section for Pharmacy Practice Managers has collaborated with Boston University to establish the PLI as a major program within the Center's portfolio and to have it serve as its capstone program. The Pharmacy Leadership Institute uses relevant program curriculum, high-quality instruction, and peer interaction to broaden business skills, managerial versatility, and the extraordinary leadership demanded of today's health-system pharmacy leaders. The experience enables pharmacist leaders to develop a new way of thinking and a new set of behaviors to meet the demanding challenges facing pharmacy. PLI graduates have become a source of leadership experts serving the Center's initiatives.Conversations with Health-System Pharmacy's Most Influential Leader's Video-ASHP past president and Whitney Award Recipient, Sara White, provided the Foundation with ongoing support and volunteered her time to help produce a series of videos with some of the most influential health-system pharmacy practice leaders. The videos are hosted on the ASHP Foundation Web site as a leadership resource and a source of motivation for health-system pharmacy professionals. Two new videos were added in the fall of 2009, expanding the total of videos to nine.Leadership Speakers Bureau-The Leadership Speakers Bureau (LSB) is the first program of the Center for Health-System Pharmacy Leadership developed specifically for students. The LSB is a collaboration of the Center and ASHP's Section of Pharmacy Practice Managers, Student and New Practitioners Forum, and the State Affiliates Division, along with external consultants. Pharmacists who are ASHP state affiliate members are the primary speakers. They draw upon their personal and professional experiences to encourage students to embrace leadership as part of their professional obligation. Supported by a grant from Roche, 14 schools of pharmacy participated in the program during FY 10.Community Health Systems Leadership Seminar Series-In February, 2010, the Center for Health-System Pharmacy Leadership launched an eight-month leadership seminar series for the pharmacists employed by Community Health Systems (CHS), the nation's third largest health system. This program has been customized to meet the key leadership needs and challenges for the CHS pharmacy leadership team across the nation. Topics include leadership subjects that have been presented in past leadership learning communities sponsored by the Center at the ASHP Summer Meeting, and are presented via live, web-based distance learning mechanisms.Leadership Resource Center- Sponsored by Baxter Healthcare, Inc., this program was developed in 2009 and launched in February of 2010 as a web-based resource that is part of the ASHP Foundation's website. The primary goal of the Leadership Resource Center is to have an ongoing and continuously updated source of leadership information and tools to assist pharmacists at all stages of their careers.Student Leadership Development Workshop-The Center for Health-System Pharmacy leadership worked with the Section of Pharmacy Practice Managers to support a series of three-hour leadership development workshops for pharmacy students at three ASHP state affiliate meetings. Discussions are underway to determine how to make this workshop an ongoing program supported by the ASHP Foundation.Pharmacy Student Clinical Skills Competition-This is the third year that the Foundation has sponsored the Pharmacy Student Clinical Skills Competition (CSC) at the ASHP Midyear Clinical Meeting. Each year the number of participating schools continues to grow and in December 2009 102 teams who won preliminary competitions at their local pharmacy schools participated in the competition. During the CSC, students demonstrate their skills by assessing patient information and current therapy, identifying and prioritizing drug therapy problems, identifying treatment goals, and recommending a pharmacist care plan. The 2009 recipients were Tamara Spraker and Sijy Mathew of the University of Texas at Austin.Demonstrating Pharmacists' Value: A Systematic Evidence Review-Dr. Marie Chisholm-Bums of the University of Arizona completed a systematic evidence review entitled "Demonstrating Pharmacists' Impact on Therapeutic, Safety, Humanistic and Economic Health Outcomes: A Systematic Review and Meta-analyses." She presented her review at the 2009 ASHP Midyear Clinical Meeting.Harvey A. K. Whitney Award Lecture Collection Program-The Harvey A.K. Whitney Award is the most prestigious award in health-system pharmacy. The Whitney Lecture Collection Program includes a web-based program for dissemination of Whitney lectures, a dessert reception following the Whitney Award dinner at the ASHP Summer Meeting, and a reception at the ASHP Midyear Clinical Meeting that enables residents to meet many of the recipients of the Whitney award. Recipients present a lecture at the award ceremony, which is later published. Since 1990, the ASHP Foundation has offered a compilation of these lectures from 1950 through present day to residents, residency directors and directors of pharmacy participating in ASHP-accredited residency programs. The current web-based site provides access to 60 lectures that can be browsed by title, author, publication date or keyword. Updates for the 2010 year include the addition of Charles D. Hepler's lecture and the addition of brief video clips containing 6 to 8 of the past recipients.Other programs-Literature Awards ProgramPharmacy Practice Model InitiativeResearch Boot CampSterile Products Outsourcing ToolWalter Jones Memorial Pharmacy Student Financial AidASHP Student Leadership AwardWilliam A. Zellmer Leadership Lecture Program</Description>
      <Activity2>
        <Expense>548257</Expense>
        <Grants>212275</Grants>
        <Description>ADVANCEMENT OF OPTIMAL PATIENT MEDICATION OUTCOMES:ASHP Foundation Junior Investigator Research Grant-Twenty-five applications were received for the ASHP Foundation Junior Investigator Research Grant during the FY 10 cycle. This grant is offered to new pharmacist investigators and is intended to support practice-based medication-use research. Grant funds are provided by the ASHP Foundation through Joseph A. Oddis Endowment. A seven-member review panel composed of pharmacist and physician researchers recommended award of the following grants: "Nonadherence with INR Monitoring and Anticoagulant Complications" which will be conducted by Daniel M. Witt, Pharm.D., of Kaiser Permanente Colorado and Mark A. Crowther, M.D. of McMaster University and "Improving Pharmacist-led Electronic Medication Reconciliation" which will be conducted by Shobha Phansalkar, R.Ph., Ph.D and David Bates, M.D. of The Brigham and Woman's Hospital. Studies funded during the FY 08 and FY 09 grant cycles progressed during FY 10.American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship-The ASHP Foundation withheld its annual funding of the AFPE Pre-Doctoral Fellowship in the spring of 2009 but was able to partner with ASHP in May of 2010 to jointly fund this fellowship in the coming year. We are awaiting the selection of the student in 2010 who will benefit from the ASHP/ASHP Foundation support.Antithrombotic Pharmacotherapy Traineeship Program-In collaboration with ASHP as part of a multi-tiered educational program, the Foundation received funding for the 2009/2010 Antithrombotic Pharmacotherapy Traineeship from sanofi-aventis. The 2009/2010 program offering was revised to include a comprehensive web-based distance education program and comparison of anti thrombotic medication related pre/post process and patient outcomes. The traineeship concluded with a 5-day structured experiential program that prepared pharmacists to establish and maintain specialized services for the management of patients' antithrombotic therapy.Critical Care Traineeship Program-This program was last conducted in May 2009 and was a program that was unfunded in FY 10. Staff continues to seek programmatic support for what is one of the most popular traineeship programs. Fed. Services Jr. Invest. Grant Program: Optimizing Chronic Drug Therapy in the Elderly- For FY 07 through FY 09, program support was provided by Abbott and the research focus was medication adherence in patients with either auto-immune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease. Research supported by the FY 07, FY 08 and FY 09 programs is ongoing.Hospital Pharmacist - Hospitalist Collaborations-Sanofi-aventis provided sponsorship for this program that studies multidisciplinary initiatives between hospitalists and hospital pharmacists focused on venous thromboembolism prevention/treatment or glycemic control in hospitalized patients. Research from these two programs from FY 07 and FY 08 is ongoing. FY 07 recipient Dr. Rachel Hroncich presented findings at the 2009 ASHP Midyear Clinical Meeting.Emergency Physician/Hospital Pharmacist Research Grant Program-Ortho-McNeil provided sponsorship for this program which supports research, conducted by hospital pharmacists and emergency physicians, related to the care of patients with infectious diseases who present to the emergency department. A ten-member review panel composed of pharmacists and emergency physicians recommended award of the following grants: "ED Pharmacists Optimize Antimicrobial Use Process in Severe Sepsis and Septic Shock," which will be conducted by Maria l. Rudis, Pharm.D. and Christopher S. Russi, D.O. of Mayo Clinic Rochester and "The Value of MRSA Nares Carriage Status for Treatment of Skin and Soft Infections in the Emergency Department," which will be conducted by Nicole M. Acquisto, Pharm.D. and Sharon G. Humiston, M.D., M.P.H. of the University of Rochester Medical Center.Oncology Patient Care Traineeship Program-Support for the 2009/2010 program was provided by Amgen. Eight trainees were selected from 24 applicants. Participants received their experiential training at the following four sites: Duke University Medical Center, The Johns Hopkins Hospital, University of Texas M.D. Anderson Cancer Center, and the University of Washington Medical Center. Pain and Palliative Care Traineeship Program-Endo Pharmaceuticals provided support for redesign of the former Pain Management Traineeship to expand its focus to include palliative care and to transform the distance education component to reach more pharmacists. The distance education program will include a Pain Management and Palliative Care Self-Assessment Tool and modules to address application of the principles of pain management and palliative care.Pharmacy Residency Excellence Awards Program-The 2009 Pharmacy Residency Excellence Awards Program was supported by Amgen, Inc. This unique national competition recognizes excellence and leadership in the training and mentoring of pharmacy residents. The objectives of this program are to: (1) recognize the achievements of residency programs and pharmacists who have demonstrated excellence and leadership in the training of pharmacy residents, and (2) to widely disseminate the results of these accomplishments to foster innovations in pharmacy resident training.Pharmacy Resident Practice-Based Research Grant Program-Sixty-five applications were received for the 2009 Pharmacy Resident Practice-Based Research Grant Program. This program was funded through the ASHP dues contribution to the Foundation. This grant is offered to pharmacy residents participating in an ASHP-accredited residency program and is intended to support health services research related to medication use.Promoting Influenza Prevention: Pharmacists as Immunization Advocates-CSL Biotherapies provided support for Promoting Influenza Prevention: Pharmacists as Immunization Advocates. This program supports demonstration projects that focus on the pharmacist's role in promoting vaccination against seasonal influenza. Two $25,000 grants are being offered through this program. Twelve applications were received for the April 16, 2010 deadline. Grantees selection is occurring during FY 11 and the research will begin during the 2010/2011 flu season.University of Alabama Musculoskeletal CERTs-Foundation staff members, Drs. Daniel Cobaugh and Cynthia LaCivita continued to collaborate with the Agency for Health Care Research and Quality (AHRQ)-funded Musculoskeletal Center for Education and Research in Therapeutics (CERTs) at the University of Alabama. In FY 10, this collaboration resulted in two publications: (1) Miller MJ, Allison JJ, Schmitt MR, Ray MN, Funkhouser EM, Cobaugh DJ, Saag KG, LaCivita C. using single-item health literacy screening questions to identify patients who read written nonsteroidal antiinflammatory medicine information provided at pharmacies; (2) Miller MJ, Schmitt MR, Allison JJ, Cobaugh DJ, Ray MN, Saag KG. The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness. Multi-Site Unsolicited Grant-In April 2008, the ASHP Foundation made a grant award to Jeffrey Rothschild, M.D. and William Churchill, R.Ph., of the Brigham and Women's Hospital, for a study entitled "Medication Errors Recovered by Emergency Department Pharmacists." This multicenter study also included the University of Wisconsin Hospitals and Clinics and Cedars Sinai Medical Center. The results of this study were presented at the 2009 Scientific Congress of the American College of Emergency Physicians and at the 2009 ASHP Midyear Clinical Meeting. Dr. Rothchild's research was also published in the Annals of Emergency Medicine.</Description>
      </Activity2>
      <Activity3>
        <Expense>472448</Expense>
        <Grants>152991</Grants>
        <Description>DESIGN AND STUDY OF SAFE AND EFFECTIVE MEDICATION-USE SYSTEMS:2009 Award for Excellence in Medication-Use Safety-Supported by a grant from the Cardinal Health Foundation, this program is designed to recognize a pharmacist-led multidisciplinary team that makes significant institution-wide system improvements relating to medication use. The program is in its sixth year and is the only national-level program that recognizes the pharmacist's leadership role in the medication-use process. The three 2009 finalist organizations were chosen from 34 applicants using structured selection criteria established by an independent multidisciplinary panel of experts in the field of medication safety and healthsystem administration. The Women &amp; Children's Hospital of Buffalo Kaleida Health System, NY received the $50,000 award. The two finalists, Henry Ford Hospital in Detroit, MI and Rex Healthcare in Raleigh, NC each received $10,000. The 2009 Award for Excellence video highlighted the success stories of the recipient and finalists and was presented to more than 8,000 pharmacists at the 2009 ASHP Midyear Clinical Meeting opening general session in December in Las Vegas, NY. A dinner was also held at the Midyear to recognize the finalist and recipient teams.Medication Safety Team Grant: Optimizing Bedside Technology Solutions-The three-year commitment from Omnicell to support this program ended in May of 2009. Research by the six recipients of this grant over a 3-year period is ongoing. Presentations by four of the grant recipients are planned for the 2010 ASHP Midyear Clinical meeting. These researchers have also begun to prepare manuscripts for submission to biomedical journals.Medication Continuity of Care Record Research-This program evaluation, sponsored with support from sanofi-aventis, is ongoing at the University of Pittsburgh School of Pharmacy. This evaluation, entitled "Development of a Continuity of Care Record: Bridging the Medication-Use Gap from Hospital to Home," is being conducted by Kim C. Coley, Pharm.D. She is studying the use of a continuity of care record and medication therapy management in the transition of patients from hospital to home.Pandemic Influenza Assessment Tool-Roche provided a grant to develop a Pandemic Readiness and Emergency Preparedness Resource Center which is available at www.pharmacyready.org. This site contains the Pandemic Influenza Assessment Tool for Health-System Pharmacy Departments(TM) along with practice resources, RSS feeds and benchmarking data. The availability of this tool was communicated to ASHP members and other health professionals through more than 40 dissemination vehicles, including the ASHP Foundation and ASHP web sites, electronic newsletters, ASHP meeting communications, and social networking sites. Between June 2009 and May 2010, during an H1N1 influenza pandemic, there were over 150,000 visits to this web-based tool.University of Iowa Medication Safety Grant-Following publication of their primary article related to this 2005 ASHP Foundation grant, Frank H. Morris, Jr., M.D and Paul W. Abramowitz, Pharm.D., of the University of Iowa Medical Center, published additional findings related to nursing perceptions about barcode-supported medication administration. (See: Morriss FH Jr, Abramowitz PW, Carmen L, Wallis AB. "Nurses Don't Hate Change" -- survey of nurses in a neonatal intensive care unit regarding the implementation, use and effectiveness of a bar code medication administration system.</Description>
      </Activity3>
      <TotalProgramServiceExpense>1788950</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc1039100001">1</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1234500001">1</ScheduleBRequired>
      <PoliticalActivities>0</PoliticalActivities>
      <LobbyingActivities>0</LobbyingActivities>
      <DonorAdvisedFunds referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFunds>
      <ConservationEasements referenceDocumentId="RetDoc1040000001">0</ConservationEasements>
      <CollectionsOfArt referenceDocumentId="RetDoc1040000001">0</CollectionsOfArt>
      <CreditCounseling referenceDocumentId="RetDoc1040000001">0</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="RetDoc1040000001">1</TermOrPermanentEndowments>
      <BalanceSheetAmountsReported referenceDocumentId="RetDoc1040000001">1</BalanceSheetAmountsReported>
      <IndependentAuditFinancialStmt referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinancialStmt>
      <School>0</School>
      <ForeignOffice>0</ForeignOffice>
      <ForeignActivities>0</ForeignActivities>
      <MoreThan5000KToOrganizations>0</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals>0</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>0</ProfessionalFundraising>
      <FundraisingActivities>1</FundraisingActivities>
      <Gaming>0</Gaming>
      <Hospital>0</Hospital>
      <GrantsToOrganizations referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizations>
      <GrantsToIndividuals referenceDocumentId="RetDoc1041900001">1</GrantsToIndividuals>
      <ScheduleJRequired referenceDocumentId="RetDoc1042400001">1</ScheduleJRequired>
      <TaxExemptBonds>0</TaxExemptBonds>
      <ExcessBenefitTransaction>0</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction>0</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP>0</LoanToOfficerOrDQP>
      <GrantToRelatedPerson>0</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization>0</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember>0</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp>0</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions>0</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>0</DeductibleContributionsOfArt>
      <Terminated>0</Terminated>
      <PartialLiquidation>0</PartialLiquidation>
      <DisregardedEntity referenceDocumentId="RetDoc1043400001">0</DisregardedEntity>
      <RelatedEntity referenceDocumentId="RetDoc1043400001">1</RelatedEntity>
      <RelatedOrgControlledEntity referenceDocumentId="RetDoc1043400001">0</RelatedOrgControlledEntity>
      <TransfersToExemptNonChrtblOrg referenceDocumentId="RetDoc1043400001">1</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPartnership>
      <ScheduleORequired>1</ScheduleORequired>
      <NumberFormsTransmittedWith1096>42</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <ComplianceWithBackupWitholding>1</ComplianceWithBackupWitholding>
      <NumberOfEmployees>0</NumberOfEmployees>
      <UnrelatedBusinessIncome>0</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>0</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>0</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>0</TaxablePartyNotification>
      <NonDeductibleContributions>0</NonDeductibleContributions>
      <QuidProQuoContributions>1</QuidProQuoContributions>
      <QuidProQuoDisclosure>1</QuidProQuoDisclosure>
      <Form8282PropertyDisposedOf>0</Form8282PropertyDisposedOf>
      <FundsToPayPremiums>0</FundsToPayPremiums>
      <PremiumsPaid>0</PremiumsPaid>
      <Form8899Filed>0</Form8899Filed>
      <Form1098CFiled>0</Form1098CFiled>
      <NbrVotingGoverningBodyMembers>11</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>9</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>1</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>0</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>0</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>0</MaterialDiversionOrMisuse>
      <MembersOrStockholders>0</MembersOrStockholders>
      <ElectionOfBoardMembers>1</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>0</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>1</MinutesOfGoverningBody>
      <MinutesOfCommittees>0</MinutesOfCommittees>
      <OfficerMailingAddress>0</OfficerMailingAddress>
      <LocalChapters>0</LocalChapters>
      <Form990ProvidedToGoverningBody>1</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>1</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>1</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>1</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>1</WhistleblowerPolicy>
      <DocumentRetentionPolicy>1</DocumentRetentionPolicy>
      <CompensationProcessCEO>1</CompensationProcessCEO>
      <CompensationProcessOther>0</CompensationProcessOther>
      <InvestmentInJointVenture>0</InvestmentInJointVenture>
      <StatesWhereCopyOfReturnIsFiled>MD</StatesWhereCopyOfReturnIsFiled>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NameBusiness>
          <BusinessNameLine1>ELIZABETH HARTNETT</BusinessNameLine1>
        </NameBusiness>
        <TelephoneNumber>3016648612</TelephoneNumber>
        <AddressUS>
          <AddressLine1>7272 WISCONSIN AVENUE 2ND FLOOR</AddressLine1>
          <City>BETHESDA</City>
          <State>MD</State>
          <ZIPCode>20814</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <Form990PartVIISectionA>
        <NamePerson>DAVID R GAUGH</NamePerson>
        <Title>CHAIR</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>JANET A SILVESTER MBA</NamePerson>
        <Title>VICE CHAIR</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>HENRI R MANASSE JR P</NamePerson>
        <Title>PRESIDENT/ASHP PRESIDENT</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>644199</ReportableCompFromRelatedOrgs>
        <OtherCompensation>74836</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>PAUL W ABRAMOWITZ PHAR</NamePerson>
        <Title>TREASURER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>STEPHEN J ALLEN MS FA</NamePerson>
        <Title>SECRETARY/EVP</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>217376</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>29535</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>BARBARA BALIK RN MS E</NamePerson>
        <Title>DIRECTOR AT LARGE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>KEVIN J COLGAN MA FA</NamePerson>
        <Title>DIRECTOR AT LARGE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>5000</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>MICHAEL S FLAGSTAD MS</NamePerson>
        <Title>DIRECTOR AT LARGE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DALLAS J HOWE</NamePerson>
        <Title>DIRECTOR AT LARGE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>BRUCE E SCOTT PHARMD</NamePerson>
        <Title>DIRECTOR AT LARGE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>GORDON S WILLCOX</NamePerson>
        <Title>DIRECTOR AT LARGE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>RICHARD WALLING</NamePerson>
        <Title>Director Ctr for Health-</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>135636</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>14825</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DANIEL COBAUGH</NamePerson>
        <Title>Sr Dir for Research and</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>127533</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>20132</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Myrna Konajeski</NamePerson>
        <Title>DIR OF DEVELOPMENT</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>103863</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>2056</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>cynthia lacivita</NamePerson>
        <Title>dir education and specia</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>104487</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>12259</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>688895</TotalReportableCompFromOrg>
      <TotalReportableCompFrmRltdOrgs>649199</TotalReportableCompFrmRltdOrgs>
      <TotalOtherCompensation>153643</TotalOtherCompensation>
      <NumberIndividualsGT100K>5</NumberIndividualsGT100K>
      <FormersListed>0</FormersListed>
      <TotalCompGT150K>1</TotalCompGT150K>
      <CompensationFromOtherSources>0</CompensationFromOtherSources>
      <NumberOfContractorsGT100K>0</NumberOfContractorsGT100K>
      <FundraisingEvents>32747</FundraisingEvents>
      <AllOtherContributions>1960828</AllOtherContributions>
      <TotalContributions>1993575</TotalContributions>
      <ProgramServiceRevenue>
        <Description>PHARMACY LEADERSHIP AC</Description>
        <BusinessCode>900099</BusinessCode>
        <TotalRevenueColumn>155612</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>155612</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <TotalProgramServiceRevenue>155612</TotalProgramServiceRevenue>
      <InvestmentIncome>
        <TotalRevenueColumn>234758</TotalRevenueColumn>
        <ExclusionAmount>234758</ExclusionAmount>
      </InvestmentIncome>
      <GrossAmountSalesAssets>
        <Securities>985679</Securities>
      </GrossAmountSalesAssets>
      <GainOrLoss>
        <Securities>985679</Securities>
      </GainOrLoss>
      <NetGainOrLossInvestments>
        <TotalRevenueColumn>985679</TotalRevenueColumn>
        <ExclusionAmount>985679</ExclusionAmount>
      </NetGainOrLossInvestments>
      <GrossIncomeFundraisingEvents>8760</GrossIncomeFundraisingEvents>
      <CntrbtnsRprtdFundraisingEvents>32747</CntrbtnsRprtdFundraisingEvents>
      <FundraisingDirectExpenses>18613</FundraisingDirectExpenses>
      <NetIncomeFromFundraisingEvents>
        <TotalRevenueColumn>-9853</TotalRevenueColumn>
        <ExclusionAmount>-9853</ExclusionAmount>
      </NetIncomeFromFundraisingEvents>
      <TotalRevenue>
        <TotalRevenueColumn>3359771</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>155612</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>1210584</ExclusionAmount>
      </TotalRevenue>
      <GrantsToDomesticOrgs>
        <Total>421110</Total>
        <ProgramServices>421110</ProgramServices>
      </GrantsToDomesticOrgs>
      <GrantsToDomesticIndividuals>
        <Total>76714</Total>
        <ProgramServices>76714</ProgramServices>
      </GrantsToDomesticIndividuals>
      <CompCurrentOfficersDirectors>
        <Total>251190</Total>
        <ProgramServices>166486</ProgramServices>
        <ManagementAndGeneral>12880</ManagementAndGeneral>
        <Fundraising>71824</Fundraising>
      </CompCurrentOfficersDirectors>
      <OtherSalariesAndWages>
        <Total>671102</Total>
        <ProgramServices>445880</ProgramServices>
        <ManagementAndGeneral>29850</ManagementAndGeneral>
        <Fundraising>195372</Fundraising>
      </OtherSalariesAndWages>
      <PensionPlanContributions>
        <Total>44810</Total>
        <ProgramServices>30448</ProgramServices>
        <ManagementAndGeneral>3752</ManagementAndGeneral>
        <Fundraising>10610</Fundraising>
      </PensionPlanContributions>
      <OtherEmployeeBenefits>
        <Total>41309</Total>
        <ProgramServices>24103</ProgramServices>
        <ManagementAndGeneral>5105</ManagementAndGeneral>
        <Fundraising>12101</Fundraising>
      </OtherEmployeeBenefits>
      <PayrollTaxes>
        <Total>49226</Total>
        <ProgramServices>38248</ProgramServices>
        <ManagementAndGeneral>3666</ManagementAndGeneral>
        <Fundraising>7312</Fundraising>
      </PayrollTaxes>
      <FeesForServicesAccounting>
        <Total>9600</Total>
        <ManagementAndGeneral>9600</ManagementAndGeneral>
      </FeesForServicesAccounting>
      <OfficeExpenses>
        <Total>24330</Total>
        <ProgramServices>18995</ProgramServices>
        <ManagementAndGeneral>1185</ManagementAndGeneral>
        <Fundraising>4150</Fundraising>
      </OfficeExpenses>
      <Occupancy>
        <Total>56790</Total>
        <ProgramServices>31206</ProgramServices>
        <ManagementAndGeneral>11948</ManagementAndGeneral>
        <Fundraising>13636</Fundraising>
      </Occupancy>
      <Travel>
        <Total>127006</Total>
        <ProgramServices>100596</ProgramServices>
        <ManagementAndGeneral>22743</ManagementAndGeneral>
        <Fundraising>3667</Fundraising>
      </Travel>
      <DepreciationDepletion>
        <Total>46400</Total>
        <ProgramServices>29356</ProgramServices>
        <ManagementAndGeneral>17044</ManagementAndGeneral>
      </DepreciationDepletion>
      <OtherExpenses>
        <Description>CONTRACT SERVICES</Description>
        <Total>392999</Total>
        <ProgramServices>343233</ProgramServices>
        <ManagementAndGeneral>34146</ManagementAndGeneral>
        <Fundraising>15620</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>GENERAL EXPENSES</Description>
        <Total>94545</Total>
        <ProgramServices>76578</ProgramServices>
        <ManagementAndGeneral>2499</ManagementAndGeneral>
        <Fundraising>15468</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>temporary services</Description>
        <Total>9220</Total>
        <ProgramServices>4610</ProgramServices>
        <ManagementAndGeneral>1383</ManagementAndGeneral>
        <Fundraising>3227</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>bank charges and misc</Description>
        <Total>6063</Total>
        <ManagementAndGeneral>6063</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>SPECIAL EVENT EXPENSE T</Description>
        <Total>-18613</Total>
        <ProgramServices>-18613</ProgramServices>
      </OtherExpenses>
      <TotalFunctionalExpenses>
        <Total>2303801</Total>
        <ProgramServices>1788950</ProgramServices>
        <ManagementAndGeneral>161864</ManagementAndGeneral>
        <Fundraising>352987</Fundraising>
      </TotalFunctionalExpenses>
      <SavingsAndTempCashInvestments>
        <BOY>703376</BOY>
        <EOY>1019149</EOY>
      </SavingsAndTempCashInvestments>
      <PledgesAndGrantsReceivable>
        <BOY>156062</BOY>
        <EOY>214572</EOY>
      </PledgesAndGrantsReceivable>
      <PrepaidExpensesDeferredCharges>
        <BOY>2918</BOY>
        <EOY>9325</EOY>
      </PrepaidExpensesDeferredCharges>
      <LandBuildingsEquipmentBasis>195413</LandBuildingsEquipmentBasis>
      <LandBldgEquipmentAccumDeprec>130081</LandBldgEquipmentAccumDeprec>
      <LandBuildingsEquipmentBasisNet>
        <BOY>82685</BOY>
        <EOY>65332</EOY>
      </LandBuildingsEquipmentBasisNet>
      <InvestmentsPubTradedSecurities>
        <BOY>7687225</BOY>
        <EOY>8377415</EOY>
      </InvestmentsPubTradedSecurities>
      <OtherAssetsTotal>
        <BOY>98560</BOY>
        <EOY>146458</EOY>
      </OtherAssetsTotal>
      <TotalAssets>
        <BOY>8730826</BOY>
        <EOY>9832251</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>114368</BOY>
        <EOY>194520</EOY>
      </AccountsPayableAccruedExpenses>
      <DeferredRevenue>
        <BOY>59406</BOY>
        <EOY>77184</EOY>
      </DeferredRevenue>
      <OtherLiabilities>
        <BOY>52475</BOY>
        <EOY>0</EOY>
      </OtherLiabilities>
      <TotalLiabilities>
        <BOY>226249</BOY>
        <EOY>271704</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>1467454</BOY>
        <EOY>1869549</EOY>
      </UnrestrictedNetAssets>
      <TemporarilyRestrictedNetAssets>
        <BOY>2266374</BOY>
        <EOY>2912954</EOY>
      </TemporarilyRestrictedNetAssets>
      <PermanentlyRestrictedNetAssets>
        <BOY>4770749</BOY>
        <EOY>4778044</EOY>
      </PermanentlyRestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>8504577</BOY>
        <EOY>9560547</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>8730826</BOY>
        <EOY>9832251</EOY>
      </TotalLiabNetAssetsFundBalances>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>0</AccountantCompileOrReview>
      <FSAudited>1</FSAudited>
      <AuditCommittee>0</AuditCommittee>
      <FinancialStatementSeparate>X</FinancialStatementSeparate>
      <FederalGrantAuditRequired>0</FederalGrantAuditRequired>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <SupportingOrganization509a3>X</SupportingOrganization509a3>
      <SupportingOrg509a3Type1>X</SupportingOrg509a3Type1>
      <ContribByControllingIndividual>0</ContribByControllingIndividual>
      <ContributionByRelatedParty>0</ContributionByRelatedParty>
      <ContribBy35ControlledEntity>0</ContribBy35ControlledEntity>
      <SupportedOrgInformation>
        <Name>
          <BusinessNameLine1>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </Name>
        <EIN>520807628</EIN>
        <TypeOfOrganization>501(c)(6)</TypeOfOrganization>
        <ListedInGoverningDoc>0</ListedInGoverningDoc>
        <SupportedOrganizationNotified>1</SupportedOrganizationNotified>
        <OrganizedInUS>1</OrganizedInUS>
        <Amount>26682</Amount>
      </SupportedOrgInformation>
      <TotalNumberOfSupportedOrgs>1</TotalNumberOfSupportedOrgs>
      <SumOfAmounts>26682</SumOfAmounts>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CurrentYear>
        <BeginningOfYearBalance>5554292</BeginningOfYearBalance>
        <Contributions>7295</Contributions>
        <InvestmentEarningsOrLosses>899095</InvestmentEarningsOrLosses>
        <OtherExpenditures>526354</OtherExpenditures>
        <EndOfYearBalance>5934328</EndOfYearBalance>
      </CurrentYear>
      <CurrentYearMinus1Year>
        <BeginningOfYearBalance>6505305</BeginningOfYearBalance>
        <Contributions>900</Contributions>
        <InvestmentEarningsOrLosses>-1659001</InvestmentEarningsOrLosses>
        <OtherExpenditures>-707088</OtherExpenditures>
        <EndOfYearBalance>5554292</EndOfYearBalance>
      </CurrentYearMinus1Year>
      <BoardDesignatedEOYBalance>0.19480</BoardDesignatedEOYBalance>
      <PermanentEndowmentEOYBalance>0.80520</PermanentEndowmentEOYBalance>
      <TermEndowmentEOYBalance>0.00000</TermEndowmentEOYBalance>
      <EndowmentsHeldByUnrelatedOrgs>0</EndowmentsHeldByUnrelatedOrgs>
      <EndowmentsHeldByRelatedOrgs>0</EndowmentsHeldByRelatedOrgs>
      <OtherLandBuildings>
        <OtherCostOrOtherBasis>195413</OtherCostOrOtherBasis>
        <Depreciation>130081</Depreciation>
        <BookValue>65332</BookValue>
      </OtherLandBuildings>
      <TotalOfBookValueLandBuildings>65332</TotalOfBookValueLandBuildings>
      <TotalRevenue>3359771</TotalRevenue>
      <TotalExpenses>2303801</TotalExpenses>
      <ExcessOrDeficitForYear>1055970</ExcessOrDeficitForYear>
      <TotalAdjustments>0</TotalAdjustments>
      <ExcessOrDeficitPerFS>1055970</ExcessOrDeficitPerFS>
      <TotRevenueEtcAuditedFinclStmt>3424805</TotRevenueEtcAuditedFinclStmt>
      <DonatedSrvcAndUseOfFacilities>46421</DonatedSrvcAndUseOfFacilities>
      <OtherRevenues>18613</OtherRevenues>
      <RevenueNotRptdF990>65034</RevenueNotRptdF990>
      <RevenueSubtotal>3359771</RevenueSubtotal>
      <RevenueNotRptdOnFinStmt>0</RevenueNotRptdOnFinStmt>
      <TotalRevenuePerForm990>3359771</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>2368835</TotExpensesEtcAuditedFinclStmt>
      <DonatedServicesUseOfFacilities>46421</DonatedServicesUseOfFacilities>
      <OtherExpensesIncluded>18613</OtherExpensesIncluded>
      <ExpensesNotRptdF990>65034</ExpensesNotRptdF990>
      <ExpensesSubtotal>2303801</ExpensesSubtotal>
      <ExpensesNotRptdOnFinStmt>0</ExpensesNotRptdOnFinStmt>
      <TotalExpensesPerForm990>2303801</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIV>
        <Identifier>Part V, Line 4:</Identifier>
        <ReturnReference>Description of Intended Use of Endowment Funds:</ReturnReference>
        <Explanation>THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH WAS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.</Explanation>
      </Form990ScheduleDPartXIV>
      <Form990ScheduleDPartXIV>
        <Identifier>Part X:</Identifier>
        <ReturnReference>Description of Uncertain Tax Positions Under FIN 48:</ReturnReference>
        <Explanation>Management did not identify any uncertain income tax positions warranting a liability accrual on the financial statements. The Foundation believes it is no longer subject to U.S. Federal, state, and local income tax examinations by taxing authorities for years beginning before 2006.</Explanation>
      </Form990ScheduleDPartXIV>
      <Form990ScheduleDPartXIV>
        <Identifier>Part XII, Line 2d - Other Adjustments:</Identifier>
        <Explanation>special event direct expenses: 18613.</Explanation>
      </Form990ScheduleDPartXIV>
      <Form990ScheduleDPartXIV>
        <Identifier>Part XIII, Line 2d - Other Adjustments:</Identifier>
        <Explanation>special event direct expenses: 18613.</Explanation>
      </Form990ScheduleDPartXIV>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="RetDoc1041300001">
      <EventsInformation>
        <NameOfEvent1>WALTER JONES GOLF CLASSIC</NameOfEvent1>
        <GrossReceiptsEvent1>41507</GrossReceiptsEvent1>
        <CharitableContributionsEvent1>32747</CharitableContributionsEvent1>
        <GrossRevenueEvent1>8760</GrossRevenueEvent1>
        <RentFacilityCostsEvent1>11101</RentFacilityCostsEvent1>
        <OtherDirectExpensesEvent1>7512</OtherDirectExpensesEvent1>
        <GrossReceiptsTotal>41507</GrossReceiptsTotal>
        <CharitableContributionsTotal>32747</CharitableContributionsTotal>
        <GrossRevenueTotalEvents>8760</GrossRevenueTotalEvents>
        <RentFacilityCostsTotalEvents>11101</RentFacilityCostsTotalEvents>
        <OtherDirectExpensesTotalEvents>7512</OtherDirectExpensesTotalEvents>
        <DirectExpenseSummaryEvents>18613</DirectExpenseSummaryEvents>
        <NetIncomeSummary>-9853</NetIncomeSummary>
      </EventsInformation>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <RecordsMaintained>1</RecordsMaintained>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>ALLINA HOSPITALS AND CLINICS</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>PO Box 43</AddressLine1>
          <City>Minneapolis</City>
          <State>MN</State>
          <ZIPCode>55440</ZIPCode>
        </AddressUS>
        <EINOfRecipient>363261413</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>12910</AmountOfCashGrant>
        <PurposeOfGrant>2009 medication safety grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>7272 Wisconsin Ave</AddressLine1>
          <City>BETHESDA</City>
          <State>MD</State>
          <ZIPCode>20814</ZIPCode>
        </AddressUS>
        <EINOfRecipient>520807628</EINOfRecipient>
        <IRCSection>501(C)(6)</IRCSection>
        <AmountOfCashGrant>26682</AmountOfCashGrant>
        <PurposeOfGrant>clinical skills competition grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>ARIZONA BOARD OF REGENTS</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>PO BOX 3308</AddressLine1>
          <City>TUCSON</City>
          <State>AZ</State>
          <ZIPCode>857223308</ZIPCode>
        </AddressUS>
        <EINOfRecipient>860779656</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>39277</AmountOfCashGrant>
        <PurposeOfGrant>jr investigator grant; pharmacist value grants</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>BIOMEDICAL RESEARCH INSTITUTE OF NEW MEXICO</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1501 SAN PEDRO DRIVE SE</AddressLine1>
          <City>ALBUQUERQUE</City>
          <State>NM</State>
          <ZIPCode>87108</ZIPCode>
        </AddressUS>
        <EINOfRecipient>850374063</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>6753</AmountOfCashGrant>
        <PurposeOfGrant>JR INVESTIGATOR GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>75 FRANCIS STREET</AddressLine1>
          <City>BOSTON</City>
          <State>MA</State>
          <ZIPCode>02115</ZIPCode>
        </AddressUS>
        <EINOfRecipient>042312909</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>39852</AmountOfCashGrant>
        <PurposeOfGrant>research grant-medical errors by emergency dept physicians</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>CINCINNATI FOUNDATION FOR BIOMEDICAL RESEARCH AND EDUCATION</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>3200 VINE STREET</AddressLine1>
          <City>CINCINNATI</City>
          <State>OH</State>
          <ZIPCode>45220</ZIPCode>
        </AddressUS>
        <EINOfRecipient>311347969</EINOfRecipient>
        <IRCSection>115</IRCSection>
        <AmountOfCashGrant>8500</AmountOfCashGrant>
        <PurposeOfGrant>FEDERAL SERVICES GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>CLEVELAND CLINICAL FOUNDATION</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>9500 EUCLID AVENUE</AddressLine1>
          <City>CLEVELAND</City>
          <State>OH</State>
          <ZIPCode>44195</ZIPCode>
        </AddressUS>
        <EINOfRecipient>340174585</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>16999</AmountOfCashGrant>
        <PurposeOfGrant>HOSPITALIST GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Duke University Medical Center</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>2301 Erwin Road</AddressLine1>
          <City>durham</City>
          <State>NC</State>
          <ZIPCode>27705</ZIPCode>
        </AddressUS>
        <EINOfRecipient>562070036</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>11000</AmountOfCashGrant>
        <PurposeOfGrant>preceptor fees: antithrombotic traineeship, oncology traineeship</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>EDWARD FOUNDATION</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>801 S WASHINGTON</AddressLine1>
          <City>NAPERVILLE</City>
          <State>IL</State>
          <ZIPCode>60540</ZIPCode>
        </AddressUS>
        <EINOfRecipient>363723705</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>13480</AmountOfCashGrant>
        <PurposeOfGrant>MEDICATION SAFETY GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Henry Ford Hospital</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>2799 west grand blvd</AddressLine1>
          <City>detroit</City>
          <State>MI</State>
          <ZIPCode>48238</ZIPCode>
        </AddressUS>
        <EINOfRecipient>381357020</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>award for excellence grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>THE JOHNS HOPKINS HOSPITAL</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>600 N WOLFE STREET</AddressLine1>
          <City>BALTIMORE</City>
          <State>MD</State>
          <ZIPCode>21287</ZIPCode>
        </AddressUS>
        <EINOfRecipient>520591656</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>preceptor fees: ONCOLOGY TRAINEESHIP</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>KAISER PERMANENTE COLORADO</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>16601 E CENTRETECH PKWY</AddressLine1>
          <City>AURORA</City>
          <State>CO</State>
          <ZIPCode>800119045</ZIPCode>
        </AddressUS>
        <EINOfRecipient>840591617</EINOfRecipient>
        <AmountOfCashGrant>6520</AmountOfCashGrant>
        <PurposeOfGrant>JUNIOR INVESTIGATOR GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>KALEIDA HEALTH</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>100 high Street</AddressLine1>
          <City>Buffalo</City>
          <State>NY</State>
          <ZIPCode>14203</ZIPCode>
        </AddressUS>
        <EINOfRecipient>161533232</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>award for excellence grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MAYO CLINIC</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>200 First Street SW</AddressLine1>
          <City>rochester</City>
          <State>MN</State>
          <ZIPCode>55905</ZIPCode>
        </AddressUS>
        <EINOfRecipient>416011702</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>21500</AmountOfCashGrant>
        <PurposeOfGrant>grants-emergency physician, pharmacy resident</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MERITER HOSPITAL PHARMACY DEPARTMENT</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>202 s park street</AddressLine1>
          <City>madison</City>
          <State>WI</State>
          <ZIPCode>53715</ZIPCode>
        </AddressUS>
        <EINOfRecipient>390806367</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>8000</AmountOfCashGrant>
        <PurposeOfGrant>preceptors fee: antithrombotic traineeship</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Palo Alto Institute for Research &amp; Education</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>431 Florence 200</AddressLine1>
          <City>Palo Alto</City>
          <State>CA</State>
          <ZIPCode>94301</ZIPCode>
        </AddressUS>
        <EINOfRecipient>770207331</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>8250</AmountOfCashGrant>
        <PurposeOfGrant>jr investigator grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>REGENTS OF UNIVERSITY OF CALIFORNIA</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>521 PARNASSUS AVENUE</AddressLine1>
          <City>SAN FRANCISCO</City>
          <State>CA</State>
          <ZIPCode>941430622</ZIPCode>
        </AddressUS>
        <EINOfRecipient>946036493</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>16396</AmountOfCashGrant>
        <PurposeOfGrant>PRECEPTORS FEE: antithrombotic traineeship</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>rex healthcare institute</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>4420 Lake Boone Trail</AddressLine1>
          <City>Raleigh</City>
          <State>NC</State>
          <ZIPCode>27607</ZIPCode>
        </AddressUS>
        <EINOfRecipient>566052117</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>award for excellence grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>SAINT LUKE'S EPISCOPAL HOSPITAL</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>6720 BERTNER</AddressLine1>
          <City>HOUSTON</City>
          <State>TX</State>
          <ZIPCode>77030</ZIPCode>
        </AddressUS>
        <EINOfRecipient>741161938</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>13080</AmountOfCashGrant>
        <PurposeOfGrant>medication safety grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF CALIFORNIA SAN DIEGO MEDICAL CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>200 WEST ARBOR DRIVE</AddressLine1>
          <City>SAN DIEGO</City>
          <State>CA</State>
          <ZIPCode>92103</ZIPCode>
        </AddressUS>
        <EINOfRecipient>956006144</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>13480</AmountOfCashGrant>
        <PurposeOfGrant>medication safety grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF IOWA</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>4 jessup hall</AddressLine1>
          <City>iowas city</City>
          <State>IA</State>
          <ZIPCode>52242</ZIPCode>
        </AddressUS>
        <EINOfRecipient>426004813</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>13200</AmountOfCashGrant>
        <PurposeOfGrant>medication safety team grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1200 N Phillips Ave</AddressLine1>
          <City>Oklahoma City</City>
          <State>OK</State>
          <ZIPCode>73104</ZIPCode>
        </AddressUS>
        <EINOfRecipient>736017987</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>5000</AmountOfCashGrant>
        <PurposeOfGrant>pharmacy resident grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF ROCHESTER MEDICAL CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>601 Elmwood Ave</AddressLine1>
          <City>rochester</City>
          <State>NY</State>
          <ZIPCode>14642</ZIPCode>
        </AddressUS>
        <EINOfRecipient>160743209</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>16500</AmountOfCashGrant>
        <PurposeOfGrant>emergency physician grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1515 holcombe blvd</AddressLine1>
          <City>houston</City>
          <State>TX</State>
          <ZIPCode>77030</ZIPCode>
        </AddressUS>
        <EINOfRecipient>746000203</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>5000</AmountOfCashGrant>
        <PurposeOfGrant>pharmacy resident grant</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF WASHINGTON MEDICAL CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1959 NE Pacific street</AddressLine1>
          <City>seattle</City>
          <State>WA</State>
          <ZIPCode>98101</ZIPCode>
        </AddressUS>
        <EINOfRecipient>916001537</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>9000</AmountOfCashGrant>
        <PurposeOfGrant>preceptor fees: antithrombotic and oncology traineeships</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>VA WESTERN NY HEALTHCARE SYSTEM</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>3495 Bailey Ave</AddressLine1>
          <City>buffalo</City>
          <State>NY</State>
          <ZIPCode>14215</ZIPCode>
        </AddressUS>
        <EINOfRecipient>161447141</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>preceptor fees: antithrombotic traineeship</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>VIRGINIA COMMONWEALTH UNIVERSITY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>PO BOX 980568</AddressLine1>
          <City>RICHMOND</City>
          <State>VA</State>
          <ZIPCode>232980568</ZIPCode>
        </AddressUS>
        <EINOfRecipient>546001758</EINOfRecipient>
        <IRCSection>115</IRCSection>
        <AmountOfCashGrant>6533</AmountOfCashGrant>
        <PurposeOfGrant>JUNIOR INVESTIGATOR GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>WISHARD MEMORIAL FOUNDATION INC</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1001 WEST 10TH STREET</AddressLine1>
          <City>iNDIANAPOLIS</City>
          <State>IN</State>
          <ZIPCode>462022879</ZIPCode>
        </AddressUS>
        <EINOfRecipient>311132066</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>13198</AmountOfCashGrant>
        <PurposeOfGrant>medication safety grant</PurposeOfGrant>
      </RecipientTable>
      <TotalNbrOf501C3AndGovtGrants>26</TotalNbrOf501C3AndGovtGrants>
      <TotalNbrOfOtherOrganizations>2</TotalNbrOfOtherOrganizations>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>leadership honoraria</TypeOfGrant>
        <NumberOfRecipients>10</NumberOfRecipients>
        <AmountOfCashGrant>25900</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>literature awards program</TypeOfGrant>
        <NumberOfRecipients>9</NumberOfRecipients>
        <AmountOfCashGrant>17500</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>multisite special honoraria</TypeOfGrant>
        <NumberOfRecipients>6</NumberOfRecipients>
        <AmountOfCashGrant>2314</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>student leadership awards</TypeOfGrant>
        <NumberOfRecipients>24</NumberOfRecipients>
        <AmountOfCashGrant>30000</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>oncology honoraria</TypeOfGrant>
        <NumberOfRecipients>2</NumberOfRecipients>
        <AmountOfCashGrant>1000</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIV>
        <Identifier>Procedure for Monitoring Grants in the U.S.:</Identifier>
        <ReturnReference>Part I, Line 2:</ReturnReference>
        <Explanation>Schedule I, Part I, Line 2: THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.</Explanation>
      </Form990ScheduleIPartIV>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommittee>X</CompensationCommittee>
      <Form990OfOtherOrganizations>X</Form990OfOtherOrganizations>
      <WrittenEmploymentContract>X</WrittenEmploymentContract>
      <CompensationSurvey>X</CompensationSurvey>
      <BoardOrCommitteeApproval>X</BoardOrCommitteeApproval>
      <SeverancePayment>0</SeverancePayment>
      <SupplementalNonqualRetirePlan>0</SupplementalNonqualRetirePlan>
      <EquityBasedCompArrangement>0</EquityBasedCompArrangement>
      <CompBasedOnRevenueOfFilingOrg>0</CompBasedOnRevenueOfFilingOrg>
      <CompBasedOnRevenueRelatedOrgs>0</CompBasedOnRevenueRelatedOrgs>
      <CompBasedNetEarningsFilingOrg>0</CompBasedNetEarningsFilingOrg>
      <CompBasedNetEarningsRelateOrgs>0</CompBasedNetEarningsRelateOrgs>
      <AnyNonFixedPayments>0</AnyNonFixedPayments>
      <InitialContractException>0</InitialContractException>
      <Form990ScheduleJPartII>
        <NameBusiness>
          <BusinessNameLine1>HENRI R MANASSE JR PHD SCD</BusinessNameLine1>
        </NameBusiness>
        <BaseCompensationFilingOrg>0</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>622498</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>21701</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>0</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>60197</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>0</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>21997</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>0</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>726393</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
      <Form990ScheduleJPartII>
        <NameBusiness>
          <BusinessNameLine1>STEPHEN J ALLEN MS FASHP</BusinessNameLine1>
        </NameBusiness>
        <BaseCompensationFilingOrg>207236</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>0</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>10140</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>24284</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>0</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>9529</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>0</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>251189</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>0</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
      <Form990ScheduleJPartII>
        <NameBusiness>
          <BusinessNameLine1>RICHARD WALLING</BusinessNameLine1>
        </NameBusiness>
        <BaseCompensationFilingOrg>133929</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>0</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>1707</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>14825</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>0</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>2133</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>0</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>152594</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>0</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section A, line 2</Identifier>
        <Explanation>Business relationship - Michael S. Flagstead and Lynnae M. Mahaney.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section A, line 7a</Identifier>
        <Explanation>THREE MANDATORY MEMBERS OF THE FOUNDATIONS BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, EXECUTIVE VICE PRESIDENT, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND EXECUTIVE VICE PRESIDENT SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section A, line 8b</Identifier>
        <Explanation>THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section B, line 11</Identifier>
        <Explanation>THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD (SERVING AS THE AUDIT COMMITTEE) BEFORE IT IS FILED. A COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section B, line 12c</Identifier>
        <Explanation>ANNUALLY AT THE MARCH MEETING</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section B, line 15a</Identifier>
        <Explanation>CEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVAULATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE COORDINATES A 360-DEGREE PERFORMANCE REVIEW, SECURING INPUT FROM THE FOUNDATION AND ASHP STAFF, FOUNDATION VOLUNTEERS, AND REPRESENTATIVES FROM THE CORPORATE COMMUNITY WHO HAVE SPONSORED PROGRAMS FOR THE FOUNDATION. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE 360-DEGREE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR CHIEF PHARMACY OFFICERS SINCE THIS IS A LIKELY AND COMPETITIVE CANDIDATE POOL FOR THE CEO POSITION, 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION, AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARDS CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARAMCIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section C, line 19</Identifier>
        <Explanation>THE FOUNDATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST PER ITS ANNUAL REPORT. THE FOUNDATION ALSO MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST.</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <Form990ScheduleRPartII>
        <NameOfDisregardedEntity>
          <BusinessNameLine1>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)</BusinessNameLine1>
        </NameOfDisregardedEntity>
        <AddressUS>
          <AddressLine1>7272 WISCONSIN AVENUE</AddressLine1>
          <City>BETHESDA</City>
          <State>MD</State>
          <ZIPCode>20814</ZIPCode>
        </AddressUS>
        <EIN>520807628</EIN>
        <PrimaryActivities>TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION</PrimaryActivities>
        <LegalDomicileState>MD</LegalDomicileState>
        <ExemptCodeSection>501(C)(6)</ExemptCodeSection>
        <DirectControllingEntityNA>N/A</DirectControllingEntityNA>
      </Form990ScheduleRPartII>
      <Form990ScheduleRPartII>
        <NameOfDisregardedEntity>
          <BusinessNameLine1>7272 WISCONSIN BUILDING CORPORATION</BusinessNameLine1>
        </NameOfDisregardedEntity>
        <AddressUS>
          <AddressLine1>7272 WISCONSIN AVENUE</AddressLine1>
          <City>BETHESDA</City>
          <State>MD</State>
          <ZIPCode>20814</ZIPCode>
        </AddressUS>
        <EIN>521760057</EIN>
        <PrimaryActivities>TITLE HOLDING COMPANY</PrimaryActivities>
        <LegalDomicileState>MD</LegalDomicileState>
        <ExemptCodeSection>501(C)(2)</ExemptCodeSection>
        <DirectControllingEntityName>
          <BusinessNameLine1>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </DirectControllingEntityName>
      </Form990ScheduleRPartII>
      <ReceiptOfIntAnnRentsRoyalties>0</ReceiptOfIntAnnRentsRoyalties>
      <GiftGrantOrCapContrToOtherOrg>1</GiftGrantOrCapContrToOtherOrg>
      <GiftGrantOrCapContrFrOtherOrg>1</GiftGrantOrCapContrFrOtherOrg>
      <LoansOrGuaranteesToOtherOrg>0</LoansOrGuaranteesToOtherOrg>
      <LoansOrGuaranteesFromOtherOrg>0</LoansOrGuaranteesFromOtherOrg>
      <SaleOfAssetsToOtherOrg>0</SaleOfAssetsToOtherOrg>
      <PurchaseOfAssetsFromOtherOrg>0</PurchaseOfAssetsFromOtherOrg>
      <ExchangeOfAssets>0</ExchangeOfAssets>
      <RentalOfFacilitiesToOtherOrgs>0</RentalOfFacilitiesToOtherOrgs>
      <RentalOfFacilitiesFrOtherOrgs>0</RentalOfFacilitiesFrOtherOrgs>
      <PerformOfServicesForOtherOrgs>0</PerformOfServicesForOtherOrgs>
      <PerformOfServicesByOtherOrgs>0</PerformOfServicesByOtherOrgs>
      <SharingOfFacilities>1</SharingOfFacilities>
      <SharingOfPaidEmployees>1</SharingOfPaidEmployees>
      <ReimbursementPaidToOtherOrg>1</ReimbursementPaidToOtherOrg>
      <ReimbursementPaidByOtherOrg>0</ReimbursementPaidByOtherOrg>
      <OtherTransferToOtherOrg>0</OtherTransferToOtherOrg>
      <OtherTransferFromOtherOrg>1</OtherTransferFromOtherOrg>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>O</TransactionType>
        <AmountInvolved>1256531</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>M</TransactionType>
        <AmountInvolved>672406</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>R</TransactionType>
        <AmountInvolved>584125</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>C</TransactionType>
        <AmountInvolved>321500</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>N</TransactionType>
        <AmountInvolved>46421</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>aMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>B</TransactionType>
        <AmountInvolved>26682</AmountInvolved>
      </TransactionsRelatedOrgsTable>
    </IRS990ScheduleR>
  </ReturnData>
</Return>